Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Poland

Poland's Stagnating Healthcare Shapes Retail Drug Market

January 2006 | Company Finance Alert

The Polish health system has a poor reputation when it comes to providing modern drugs, and lags behind many neighbours in Eastern Europe. A number of hi-tech drugs available in Bulgaria and Latvia cannot be obtained in Poland, due to the country's low health expenditure. Multinational drugmakers have frequently criticised the reimbursement list, which excludes innovative drugs, claiming that the system is designed to shelter local

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
Progress Notable If Unpredictable

Companies / Poland The strong start to 2007 appears to be continuing with
July 2007
Poland To Reform Healthcare

Companies / Poland Poland is set to reform its under-funded healthcare system in May, following protests in April by doctors over their inadequate
May 2006
Polish Drug Firm Association Creates Stricter Ethics Code

Companies / Poland Poland's association of innovative pharmaceutical companies - the SPIFF - has drawn up a stricter code of marketing ethics to prevent corruption and undesirable advertising practices. The updated code...
April 2006
Polish Pharmaceutical Exports Rise

Companies / Poland Pharmaceutical exports from Poland reached US$300mn in 2005, according to the Polish Information and Foreign Investment Agency. Key destinations were in Eastern Europe and Poland's main EU trading partner...
April 2006
Poland Awaits New Drug Reimbursement List

Companies / Poland The Polish Health Minister has declared that the new drug reimbursement list will be introduced in May 2006. The amended list will add transparency and will be expanded to include reimbursement for innovative...
February 2006
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS